15-min delayed · Sep 9, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Harte Hanks Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $17.50 to $17.50, so the covering firms are broadly aligned. The average target of $17.50 sits 314% above the current $4.22. On the fundamentals, the Street sees consensus EPS building from about $0.00 next quarter toward $0.00 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy1100%
Buy00%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Harte Hanks Inc.
12-MONTH PRICE TARGET
$17.50
+314.2% upside
Average analyst target vs $4.22 current
Highest Target$17.50
Average Target$17.50
Lowest Target$17.50
HHS EPS & revenue forecast
EPS · NEXT QUARTER
$0.00
Range $0.00 – $0.00 · 0 analysts · -100% YoY
Next period, 0 analysts expect Harte Hanks Inc to earn $0.00 a share (range $0.00 – $0.00), versus $0.06 a year earlier. , growing to $0.00 the year after.
REVENUE · NEXT QUARTER
—
Range — – — · 0 analysts
Revenue is expected to reach — (range — – —).
Top analysts covering Harte Hanks Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HHS.
#1
Puneet Souda
Leerink Partners
Buy
No targeton HHS
Coverage
—
+ Follow
HHS stock forecast FAQ
Is HHS stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover HHS?+
1 analysts have an active rating on Harte Hanks Inc.
Who is the most accurate analyst covering HHS?+
Among analysts who currently cover HHS, Puneet Souda of Leerink Partners has the strongest overall Quantellect track record. Their current call is Buy.
What is Harte Hanks Inc's projected EPS for next quarter?+
The consensus estimate is $0.00 per share (range $0.00 – $0.00) across 0 analysts, rising to $0.00 the following year.
How much revenue is Harte Hanks Inc expected to report next quarter?+
Consensus revenue is — (range — – —), growing to — next year.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HHS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
